The Wall Street Journal’s Venture Capital Pro quoted a recent biopharma report from William Blair’s equity capital markets team, noting the uptick in activity for PIPEs among biopharma companies in 2023.
Investment Banking
Equity Capital Markets Team Quoted by The Wall Street Journal
Delivered to Your Inbox
Stay up-to-date with the latest William Blair news and insights
Our Latest News
-
William Blair Acts as Joint Bookrunner on Accelerant’s Initial Public Offering
William Blair acted as a joint bookrunner on a $832 million initial public offering for Accelerant Holdings (NYSE: ARX), a data-driven risk exchange connecting underwriters of specialty insurance risk with risk capital providers.
-
-